Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir

AIDS. 2006 Jun 26;20(10):1465-7. doi: 10.1097/01.aids.0000233587.94961.4f.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active / methods
  • Drug Resistance, Multiple, Viral
  • Enfuvirtide
  • Female
  • HIV Envelope Protein gp41 / therapeutic use*
  • HIV Infections / prevention & control*
  • HIV-1 / drug effects*
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Peptide Fragments / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pyridines / therapeutic use*
  • Pyrones / therapeutic use*
  • Sulfonamides

Substances

  • HIV Envelope Protein gp41
  • Peptide Fragments
  • Pyridines
  • Pyrones
  • Sulfonamides
  • Enfuvirtide
  • tipranavir